Catalyst overview
Research summary
This catalyst tracks a Phase 1/2 data readout for AMT-260 in Mesial temporal lobe epilepsy (MTLE). The expected timing is based on the latest available company guidance and may change.
07/29/26:- First-cohort data reported; second cohort completion Q3 2026; updated Ph1/2a results H1 2027.
Verification
Confirm timing and program details against the company announcement or filing.